-
1
Real‐World Prevalence, Treatment Patterns, and Outcomes for Patients With HER2 (ERBB2)‐Mutant Metastatic Non‐Small Cell Lung Cancer, From a US‐Based Clinico‐Genomic Database...
Published 2024-12-01Subjects: “…advanced non–small cell lung cancer…”
Get full text
Article -
2
Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer
Published 2025-01-01Subjects: “…Advanced non-small cell lung cancer…”
Get full text
Article -
3
Lower respiratory tract microbiome dysbiosis impairs clinical responses to immune checkpoint blockade in advanced non‐small‐cell lung cancer
Published 2025-01-01Subjects: “…advanced non‐small‐cell lung cancer…”
Get full text
Article